<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36224351</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Structural analysis of the overoxidized Cu/Zn-superoxide dismutase in ROS-induced ALS filament formation.</ArticleTitle><Pagination><StartPage>1085</StartPage><MedlinePgn>1085</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1085</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-022-04017-0</ELocationID><Abstract><AbstractText>Eukaryotic Cu, Zn-superoxide dismutase (SOD1) is primarily responsible for cytotoxic filament formation in amyotrophic lateral sclerosis (ALS) neurons. Two cysteine residues in SOD1 form an intramolecular disulfide bond. This study aims to explore the molecular mechanism of SOD1 filament formation by cysteine overoxidation in sporadic ALS (sALS). In this study, we determined the crystal structure of the double mutant (C57D/C146D) SOD1 that mimics the overoxidation of the disulfide-forming cysteine residues. The structure revealed the open and relaxed conformation of loop IV containing the mutated Asp57. The double mutant SOD1 produced more contagious filaments than wild-type protein, promoting filament formation of the wild-type SOD1 proteins. Importantly, we further found that HOCl treatment to the wild-type SOD1 proteins facilitated their filament formation. We propose a feasible mechanism for SOD1 filament formation in ALS from the wild-type SOD1, suggesting that overoxidized SOD1 is a triggering factor of sALS. Our findings extend our understanding of other neurodegenerative disorders associated with ROS stresses at the molecular level.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Yeongjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology, and Research Institute of Agriculture and Life Sciences, CALS, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Tae-Gyun</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, College of Natural Science, Pusan National University, Busan, 46241, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Jinsook</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4175-5181</Identifier><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology, and Research Institute of Agriculture and Life Sciences, CALS, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Food and Bioconvergence, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomolecular and Cellular Structure, Institute for Basic Science (IBS), Daejeon, 34126, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dukwon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology, and Research Institute of Agriculture and Life Sciences, CALS, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Yonghoon</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3252-7846</Identifier><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology, and Research Institute of Agriculture and Life Sciences, CALS, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Bum-Joon</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0002-6037-7219</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, College of Natural Science, Pusan National University, Busan, 46241, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Nam-Chul</ForeName><Initials>NC</Initials><Identifier Source="ORCID">0000-0003-4813-748X</Identifier><AffiliationInfo><Affiliation>Department of Agricultural Biotechnology, and Research Institute of Agriculture and Life Sciences, CALS, Seoul National University, Seoul, 08826, Republic of Korea. hanc210@snu.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Food and Bioconvergence, Seoul National University, Seoul, 08826, Republic of Korea. hanc210@snu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004220">Disulfides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI="D003545">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004220" MajorTopicYN="N">Disulfides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36224351</ArticleId><ArticleId IdType="pmc">PMC9556535</ArticleId><ArticleId IdType="doi">10.1038/s42003-022-04017-0</ArticleId><ArticleId IdType="pii">10.1038/s42003-022-04017-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 2018;21:1332&#x2013;1340. doi: 10.1038/s41593-018-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine JS, Doucette PA, Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 2005;74:563&#x2013;593. doi: 10.1146/annurev.biochem.72.121801.161647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161647</ArticleId><ArticleId IdType="pubmed">15952898</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Ying Z, Wang G. Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains. J. Biol. Chem. 2012;287:28576&#x2013;28585. doi: 10.1074/jbc.M111.299990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.299990</ArticleId><ArticleId IdType="pmc">PMC3436588</ArticleId><ArticleId IdType="pubmed">22761419</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg SJ, et al. Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity. Proc. Natl Acad. Sci. USA. 2012;109:15811&#x2013;15816. doi: 10.1073/pnas.1205829109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1205829109</ArticleId><ArticleId IdType="pmc">PMC3465386</ArticleId><ArticleId IdType="pubmed">22967507</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, B. W., Ryu, J., Jeong, Y. E., Kim, J. &amp; Martin, L. J. Human motor neurons with SOD1-G93A mutation generated from CRISPR/Cas9 gene-edited iPSCs develop pathological features of amyotrophic lateral sclerosis. Front. Cell. Neurosci.14, 604171 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7710664</ArticleId><ArticleId IdType="pubmed">33328898</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu AY, et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 1995;6:349&#x2013;362. doi: 10.1006/mcne.1995.1027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.1995.1027</ArticleId><ArticleId IdType="pubmed">8846004</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E, et al. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis. Mol. neurodegeneration. 2019;14:1&#x2013;21. doi: 10.1186/s13024-019-0341-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0341-5</ArticleId><ArticleId IdType="pmc">PMC6862823</ArticleId><ArticleId IdType="pubmed">31744522</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci. Rep. 2018;8:1&#x2013;13. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front. Cell. Neurosci. 2013;7:253. doi: 10.3389/fncel.2013.00253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ, Ince PG, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol.: Off. J. Am. Neurological Assoc. Child Neurol. Soc. 1995;38:691&#x2013;695. doi: 10.1002/ana.410380424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380424</ArticleId><ArticleId IdType="pubmed">7574472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante RJ, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. neurochemistry. 1997;69:2064&#x2013;2074. doi: 10.1046/j.1471-4159.1997.69052064.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69052064.x</ArticleId><ArticleId IdType="pubmed">9349552</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RG, Henry YK, Mattson MP, Appel SH. Presence of 4&#x2010;hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol.: Off. J. Am. Neurological Assoc. Child Neurol. Soc. 1998;44:696&#x2013;699. doi: 10.1002/ana.410440419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440419</ArticleId><ArticleId IdType="pubmed">9778272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, et al. Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PloS one. 2008;3:e2849. doi: 10.1371/journal.pone.0002849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002849</ArticleId><ArticleId IdType="pmc">PMC2481395</ArticleId><ArticleId IdType="pubmed">18682740</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollari E, Goldsteins G, Bart G, Koistinaho J, Giniatullin R. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014;8:131. doi: 10.3389/fncel.2014.00131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00131</ArticleId><ArticleId IdType="pmc">PMC4026683</ArticleId><ArticleId IdType="pubmed">24860432</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph. Lateral Scler. 2009;10:191&#x2013;204. doi: 10.1080/17482960802549739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802549739</ArticleId><ArticleId IdType="pubmed">19263258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472&#x2013;476. doi: 10.1093/brain/awh373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh373</ArticleId><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel EL. Football increases the risk for Lou Gehrig&#x2019;s disease, amyotrophic lateral sclerosis. Percept. Mot. skills. 2007;104:1251&#x2013;1254. doi: 10.2466/pms.104.4.1251-1254.</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/pms.104.4.1251-1254</ArticleId><ArticleId IdType="pubmed">17879657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph. lateral Scler. 2009;10:205&#x2013;209. doi: 10.1080/17482960902721634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960902721634</ArticleId><ArticleId IdType="pubmed">19267274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79:1970&#x2013;1974. doi: 10.1212/WNL.0b013e31826daf50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826daf50</ArticleId><ArticleId IdType="pmc">PMC4098841</ArticleId><ArticleId IdType="pubmed">22955124</ArticleId></ArticleIdList></Reference><Reference><Citation>FELMUS MT, PATTEN BM, SWANKE L. Antecedent events in amyotrophic lateral sclerosis. Neurology. 1976;26:167&#x2013;167. doi: 10.1212/WNL.26.2.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.26.2.167</ArticleId><ArticleId IdType="pubmed">946326</ArticleId></ArticleIdList></Reference><Reference><Citation>Granieri E, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964&#x2013;1982. Neurology. 1988;38:1604&#x2013;1604. doi: 10.1212/WNL.38.10.1604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.38.10.1604</ArticleId><ArticleId IdType="pubmed">3419606</ArticleId></ArticleIdList></Reference><Reference><Citation>Roelofs-Iverson RA, Mulder DW, Elveback LR, Kurland LT, Molgaard CA. ALS and heavy metals: A pilot case&#x2010;control study. Neurology. 1984;34:393&#x2013;393. doi: 10.1212/WNL.34.3.393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.34.3.393</ArticleId><ArticleId IdType="pubmed">6538286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregoire N, Serratrice G. Risk factors in amyotrophic lateral sclerosis. Initial results apropos 35 cases. Rev. neurologique. 1991;147:706&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">1775824</ArticleId></ArticleIdList></Reference><Reference><Citation>Savica, R., Parisi, J. E., Wold, L. E., Josephs, K. A. &amp; Ahlskog, J. E. Mayo Clinic Proceedings (Elsevier, 2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538465</ArticleId><ArticleId IdType="pubmed">22469346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, et al. The disulfide bond, but not zinc or dimerization, controls initiation and seeded growth in amyotrophic lateral sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) fibrillation. J. Biol. Chem. 2015;290:30624&#x2013;30636. doi: 10.1074/jbc.M115.666503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.666503</ArticleId><ArticleId IdType="pmc">PMC4683282</ArticleId><ArticleId IdType="pubmed">26511321</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Torres AS, O&#x2019;Halloran TV. Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J. 2004;23:2872&#x2013;2881. doi: 10.1038/sj.emboj.7600276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600276</ArticleId><ArticleId IdType="pmc">PMC1150991</ArticleId><ArticleId IdType="pubmed">15215895</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I, et al. The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension. Acta neuropathologica. 2019;138:85&#x2013;101. doi: 10.1007/s00401-019-01986-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01986-1</ArticleId><ArticleId IdType="pmc">PMC6570705</ArticleId><ArticleId IdType="pubmed">30863976</ArticleId></ArticleIdList></Reference><Reference><Citation>De Belleroche J, Orrell R, King A. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J. Med. Genet. 1995;32:841. doi: 10.1136/jmg.32.11.841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.32.11.841</ArticleId><ArticleId IdType="pmc">PMC1051731</ArticleId><ArticleId IdType="pubmed">8592323</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, et al. Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J. Biol. Chem. 2005;280:11648&#x2013;11655. doi: 10.1074/jbc.M414327200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M414327200</ArticleId><ArticleId IdType="pubmed">15659387</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins D, English AM. SOD1 oxidation and formation of soluble aggregates in yeast: relevance to sporadic ALS development. Redox Biol. 2014;2:632&#x2013;639. doi: 10.1016/j.redox.2014.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2014.03.005</ArticleId><ArticleId IdType="pmc">PMC4052529</ArticleId><ArticleId IdType="pubmed">24936435</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee S, Jeong W, Chang T-S, Woo H. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int. 2007;72:S3&#x2013;S8. doi: 10.1038/sj.ki.5002380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002380</ArticleId><ArticleId IdType="pubmed">17653208</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim JC, et al. Irreversible oxidation of the active-site cysteine of peroxiredoxin to cysteine sulfonic acid for enhanced molecular chaperone activity&#x2217;. J. Biol. Chem. 2008;283:28873&#x2013;28880. doi: 10.1074/jbc.M804087200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804087200</ArticleId><ArticleId IdType="pmc">PMC2662001</ArticleId><ArticleId IdType="pubmed">18725414</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulsen CE, Carroll KS. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem. Rev. 2013;113:4633&#x2013;4679. doi: 10.1021/cr300163e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr300163e</ArticleId><ArticleId IdType="pmc">PMC4303468</ArticleId><ArticleId IdType="pubmed">23514336</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo I, et al. Structural details of the OxyR peroxide-sensing mechanism. Proc. Natl Acad. Sci. USA. 2015;112:6443&#x2013;6448. doi: 10.1073/pnas.1424495112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1424495112</ArticleId><ArticleId IdType="pmc">PMC4443364</ArticleId><ArticleId IdType="pubmed">25931525</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala FA, Wright GSA, Antonyuk SV, Garratt RC, Hasnain SS. Molecular recognition and maturation of SOD1 by its evolutionarily destabilised cognate chaperone hCCS. PLoS Biol. 2019;17:e3000141. doi: 10.1371/journal.pbio.3000141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000141</ArticleId><ArticleId IdType="pmc">PMC6383938</ArticleId><ArticleId IdType="pubmed">30735496</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek Y, et al. Structure and function of the hypochlorous acid&#x2013;induced flavoprotein RclA from Escherichia coli. J. Biol. Chem. 2020;295:3202&#x2013;3212. doi: 10.1074/jbc.RA119.011530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.011530</ArticleId><ArticleId IdType="pmc">PMC7062163</ArticleId><ArticleId IdType="pubmed">31988242</ArticleId></ArticleIdList></Reference><Reference><Citation>Permanne B, et al. Quantitation of Alzheimer&#x2019;s amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay. Brain Res. 1995;685:154&#x2013;162. doi: 10.1016/0006-8993(95)00431-O.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(95)00431-O</ArticleId><ArticleId IdType="pubmed">7583241</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, et al. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria. Acta Neuropathol. Commun. 2016;4:1&#x2013;14. doi: 10.1186/s40478-016-0313-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0313-8</ArticleId><ArticleId IdType="pmc">PMC4847257</ArticleId><ArticleId IdType="pubmed">27121871</ArticleId></ArticleIdList></Reference><Reference><Citation>Auclair JR, et al. Structural consequences of cysteinylation of Cu/Zn-superoxide dismutase. Biochemistry. 2013;52:6145&#x2013;6150. doi: 10.1021/bi400613h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi400613h</ArticleId><ArticleId IdType="pmc">PMC3859770</ArticleId><ArticleId IdType="pubmed">23919400</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazdag EM, et al. Purification and crystallization of human Cu/Zn superoxide dismutase recombinantly produced in the protozoan Leishmania tarentolae. Acta Crystallogr. F Struct. Biol. Cryst. Commun. 2010;66:871&#x2013;877. doi: 10.1107/S1744309110019330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S1744309110019330</ArticleId><ArticleId IdType="pmc">PMC2917280</ArticleId><ArticleId IdType="pubmed">20693657</ArticleId></ArticleIdList></Reference><Reference><Citation>DiDonato M, et al. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J. Mol. Biol. 2003;332:601&#x2013;615. doi: 10.1016/S0022-2836(03)00889-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(03)00889-1</ArticleId><ArticleId IdType="pubmed">12963370</ArticleId></ArticleIdList></Reference><Reference><Citation>Parge HE, Hallewell RA, Tainer JA. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc. Natl Acad. Sci. USA. 1992;89:6109&#x2013;6113. doi: 10.1073/pnas.89.13.6109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.13.6109</ArticleId><ArticleId IdType="pmc">PMC49447</ArticleId><ArticleId IdType="pubmed">1463506</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjula R, Wright GS, Strange RW, Padmanabhan B. Assessment of ligand binding at a site relevant to SOD 1 oxidation and aggregation. FEBS Lett. 2018;592:1725&#x2013;1737. doi: 10.1002/1873-3468.13055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13055</ArticleId><ArticleId IdType="pubmed">29679384</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange RW, et al. The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J. Mol. Biol. 2003;328:877&#x2013;891. doi: 10.1016/S0022-2836(03)00355-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(03)00355-3</ArticleId><ArticleId IdType="pubmed">12729761</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange RW, et al. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. J. Mol. Biol. 2006;356:1152&#x2013;1162. doi: 10.1016/j.jmb.2005.11.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.11.081</ArticleId><ArticleId IdType="pubmed">16406071</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange RW, Yong CW, Smith W, Hasnain SS. Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu-Zn superoxide dismutase. Proc. Natl Acad. Sci. USA. 2007;104:10040&#x2013;10044. doi: 10.1073/pnas.0703857104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0703857104</ArticleId><ArticleId IdType="pmc">PMC1885824</ArticleId><ArticleId IdType="pubmed">17548825</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsson J, Kurnik M, Lang L, Oliveberg M. Cutting off functional loops from homodimeric enzyme superoxide dismutase 1 (SOD1) leaves monomeric &#x3b2;-barrels. J. Biol. Chem. 2011;286:33070&#x2013;33083. doi: 10.1074/jbc.M111.251223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.251223</ArticleId><ArticleId IdType="pmc">PMC3190884</ArticleId><ArticleId IdType="pubmed">21700707</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Cramaro F, Del Conte R, Viezzoli MS. The solution structure of reduced dimeric copper zinc superoxide dismutase: the structural effects of dimerization. Eur. J. Biochem. 2002;269:1905&#x2013;1915. doi: 10.1046/j.1432-1033.2002.02840.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1033.2002.02840.x</ArticleId><ArticleId IdType="pubmed">11952792</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright, G. S., Antonyuk, S. V. &amp; Hasnain, S. S. The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis. Q Rev. Biophys.52, e12 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31760962</ArticleId></ArticleIdList></Reference><Reference><Citation>Borders CL, Jr, Saunders JE, Blech D, Fridovich I. Essentiality of the active-site arginine residue for the normal catalytic activity of Cu, Zn superoxide dismutase. Biochemical J. 1985;230:771&#x2013;776. doi: 10.1042/bj2300771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2300771</ArticleId><ArticleId IdType="pmc">PMC1152682</ArticleId><ArticleId IdType="pubmed">4062877</ArticleId></ArticleIdList></Reference><Reference><Citation>Naiki H, Higuchi K, Hosokawa M, Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem. 1989;177:244&#x2013;249. doi: 10.1016/0003-2697(89)90046-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(89)90046-8</ArticleId><ArticleId IdType="pubmed">2729542</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs MR, Bromley EH, Donald AM. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J. Struct. Biol. 2005;149:30&#x2013;37. doi: 10.1016/j.jsb.2004.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2004.08.002</ArticleId><ArticleId IdType="pubmed">15629655</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanh NT, Maclean N, Mahiddine S. Mechanisms of nucleation and growth of nanoparticles in solution. Chem. Rev. 2014;114:7610&#x2013;7630. doi: 10.1021/cr400544s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr400544s</ArticleId><ArticleId IdType="pubmed">25003956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Cashman NR. Prion-like mechanisms in amyotrophic lateral sclerosis. Handb. Clin. Neurol. 2018;153:337&#x2013;354. doi: 10.1016/B978-0-444-63945-5.00018-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63945-5.00018-0</ArticleId><ArticleId IdType="pubmed">29887144</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe4;uer S, Zimyanin V, Hermann A. Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis. J. Neural Transm. 2018;125:591&#x2013;613. doi: 10.1007/s00702-018-1851-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-018-1851-y</ArticleId><ArticleId IdType="pubmed">29417336</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Cashman NR. Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis. Prion. 2014;8:33&#x2013;41. doi: 10.4161/pri.27602.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.27602</ArticleId><ArticleId IdType="pmc">PMC7030911</ArticleId><ArticleId IdType="pubmed">24394345</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Fernando SM, Cashman NR. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis. Neurobiol. Dis. 2015;77:257&#x2013;265. doi: 10.1016/j.nbd.2015.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.02.009</ArticleId><ArticleId IdType="pubmed">25701498</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Kim H-J. Prion-like mechanism in amyotrophic lateral sclerosis: are protein aggregates the key? Exp. Neurobiol. 2015;24:1. doi: 10.5607/en.2015.24.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.1.1</ArticleId><ArticleId IdType="pmc">PMC4363329</ArticleId><ArticleId IdType="pubmed">25792864</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Plotkin SS, Yerbury JJ, Cashman NR. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One. 2010;5:e11552. doi: 10.1371/journal.pone.0011552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzi SA, Urushitani M, Julien JP. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 2007;102:170&#x2013;178. doi: 10.1111/j.1471-4159.2007.04531.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04531.x</ArticleId><ArticleId IdType="pubmed">17394546</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y. Pathological roles of wild-type cu, zn-superoxide dismutase in amyotrophic lateral sclerosis. Neurol. Res Int. 2012;2012:323261. doi: 10.1155/2012/323261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/323261</ArticleId><ArticleId IdType="pmc">PMC3395178</ArticleId><ArticleId IdType="pubmed">22830015</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CV, Rogers LK, Garcia-Prats AJ, Gu ZW. Oxidation of Cysteine residues in proteins by Myeloperoxidase (MPO) or HOCl in vitro produces Sulfenyl and Sulfonyl chloride intermediates&#x2020; 1140. Pediatr. Res. 1998;43:196&#x2013;196.</Citation></Reference><Reference><Citation>Pokrishevsky E, et al. Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells. Sci. Rep. 2018;8:15590. doi: 10.1038/s41598-018-32835-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32835-y</ArticleId><ArticleId IdType="pmc">PMC6197196</ArticleId><ArticleId IdType="pubmed">30349065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida M, et al. Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions. J. Biochem. 2016;159:247&#x2013;260. doi: 10.1093/jb/mvv091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvv091</ArticleId><ArticleId IdType="pmc">PMC4948195</ArticleId><ArticleId IdType="pubmed">26319711</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee V, et al. Superoxide Dismutase 1 (SOD1)-derived peptide inhibits amyloid aggregation of familial amyotrophic lateral sclerosis SOD1 mutants. ACS Chem. Neurosci. 2016;7:1595&#x2013;1606. doi: 10.1021/acschemneuro.6b00227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00227</ArticleId><ArticleId IdType="pubmed">27540759</ArticleId></ArticleIdList></Reference><Reference><Citation>Shvil N, et al. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS. Cell Death Dis. 2018;9:107. doi: 10.1038/s41419-017-0130-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0130-4</ArticleId><ArticleId IdType="pmc">PMC5833700</ArticleId><ArticleId IdType="pubmed">29371591</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida T, Watari H. Changes in intracellular pH during repeated exercise. Eur. J. Appl. Physiol. Occup. Physiol. 1993;67:274&#x2013;278. doi: 10.1007/BF00864228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00864228</ArticleId><ArticleId IdType="pubmed">8223543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahlin K, Alvestrand A, Brandt R, Hultman E. Intracellular pH and bicarbonate concentration in human muscle during recovery from exercise. J. Appl. Physiol. 1978;45:474&#x2013;480. doi: 10.1152/jappl.1978.45.3.474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1978.45.3.474</ArticleId><ArticleId IdType="pubmed">29868</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga S, Shiojiri T, Kondo N, Barstow TJ. Effect of increased muscle temperature on oxygen uptake kinetics during exercise. J. Appl. Physiol. 1997;83:1333&#x2013;1338. doi: 10.1152/jappl.1997.83.4.1333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1997.83.4.1333</ArticleId><ArticleId IdType="pubmed">9338444</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuzuki T, et al. Body temperature elevation during exercise is essential for activating the Akt signaling pathway in the skeletal muscle of type 2 diabetic rats. PloS One. 2018;13:e0205456. doi: 10.1371/journal.pone.0205456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0205456</ArticleId><ArticleId IdType="pmc">PMC6179285</ArticleId><ArticleId IdType="pubmed">30304029</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez&#x2010;Alonso J, Quistorff B, Krustrup P, Bangsbo J, Saltin B. Heat production in human skeletal muscle at the onset of intense dynamic exercise. J. Physiol. 2000;524:603&#x2013;615. doi: 10.1111/j.1469-7793.2000.00603.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.2000.00603.x</ArticleId><ArticleId IdType="pmc">PMC2269891</ArticleId><ArticleId IdType="pubmed">10766936</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, et al. Human superoxide dismutase 1 (hSOD1) maturation through interaction with human copper chaperone for SOD1 (hCCS) Proc. Natl Acad. Sci. USA. 2012;109:13555&#x2013;13560. doi: 10.1073/pnas.1207493109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207493109</ArticleId><ArticleId IdType="pmc">PMC3427097</ArticleId><ArticleId IdType="pubmed">22869735</ArticleId></ArticleIdList></Reference><Reference><Citation>Elam JS, et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Mol. Biol. 2003;10:461&#x2013;467. doi: 10.1038/nsb935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb935</ArticleId><ArticleId IdType="pubmed">12754496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hough MA, et al. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl Acad. Sci. USA. 2004;101:5976&#x2013;5981. doi: 10.1073/pnas.0305143101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0305143101</ArticleId><ArticleId IdType="pmc">PMC395908</ArticleId><ArticleId IdType="pubmed">15056757</ArticleId></ArticleIdList></Reference><Reference><Citation>YoulPark S, GilKim Y. The protein crystallography beamlines at the pohang light source II. Biodesign. 2017;5:30&#x2013;34.</Citation></Reference><Reference><Citation>Otwinowski, Z. &amp; Minor, W. in Methods in Enzymology Vol. 276 (eds Abelson, J) 307&#x2013;326 (Elsevier, 1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">27754618</ArticleId></ArticleIdList></Reference><Reference><Citation>Winn MD, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 2011;67:235&#x2013;242. doi: 10.1107/S0907444910045749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910045749</ArticleId><ArticleId IdType="pmc">PMC3069738</ArticleId><ArticleId IdType="pubmed">21460441</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004;60:2126&#x2013;2132. doi: 10.1107/S0907444904019158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444904019158</ArticleId><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonine PV, et al. Joint X-ray and neutron refinement with phenix. refine. Acta Crystallogr. D Biol. Crystallogr. 2010;66:1153&#x2013;1163. doi: 10.1107/S0907444910026582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910026582</ArticleId><ArticleId IdType="pmc">PMC2967420</ArticleId><ArticleId IdType="pubmed">21041930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Akter KF, Rahman MM, Naidu R. The separation of arsenic species in soils and plant tissues by anion-exchange chromatography with inductively coupled mass spectrometry using various mobile phases. Microchemical J. 2008;89:20&#x2013;28. doi: 10.1016/j.microc.2007.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.microc.2007.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>McCord JM, Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein) J. Biol. Chem. 1969;244:6049&#x2013;6055. doi: 10.1016/S0021-9258(18)63504-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)63504-5</ArticleId><ArticleId IdType="pubmed">5389100</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>